The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Q&A: San­doz CEO Richard Saynor on gener­ic GLP-1s, Trump's in­dus­try im­pact, and Mark Cuban's com­pa­ny

Last month
People
Pharma

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

Last month
Pharma

Sanofi’s vac­cine tech trans­fer in Viet­nam; Al­mac’s £1B+ rev­enue mile­stone

Last month

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

Last month
FDA+

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

Last month
Pharma

FDA re­jects Savara’s rare lung dis­ease drug over lim­it­ed man­u­fac­tur­ing da­ta

Last month
Pharma
FDA+

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

Last month
Pharma
Law

FDA names act­ing head of in­spec­tions; J&J again ad­vo­cates for tax poli­cies as al­ter­na­tive to tar­iffs

Last month

Meet the ‘first sale’ rule: A cus­toms loop­hole phar­ma com­pa­nies could use to ease tar­iff im­pact

Last month
Pharma

Sam­sung Bi­o­log­ics to sep­a­rate man­u­fac­tur­ing and biosim­i­lar busi­ness­es

Last month

FDA an­nounces ef­forts to fa­cil­i­tate drug im­por­ta­tion from Cana­da 

Last month
Pharma
FDA+

Mark Cuban com­pounder joins Trump's new man­u­fac­tur­ing ini­tia­tive

Last month
Pharma

'Go ahead and do it': Top RFK Jr. deputy dares drug­mak­ers that might pull man­u­fac­tur­ing over new price pres­sure

Last month
Pharma

AGC Bio se­cures lentivi­ral con­tract; Ther­mo Fish­er to make Cy­bin as­set

Last month

Up­dat­ed: Mer­ck KGaA con­tin­ues US tar­iff sur­charge but at a 'de­creased' rate 

Last month
China
Pharma

Sanofi touts $20B in­vest­ment in US over five years

Last month
Pharma

Some gener­ics, biosim­i­lar drug­mak­ers say they can with­stand tar­iff im­pact

2 months ago
Pharma

Roche could re­think $50B US ex­pan­sion plan if new poli­cies 'har­m' op­er­a­tions

2 months ago
Pharma

Io­vance stock plum­mets af­ter low­ered full-year guid­ance, missed an­a­lyst ex­pec­ta­tions for Am­tagvi

2 months ago
Pharma

Lon­za says its US-based sites are in high de­mand as phar­ma tar­iffs near

2 months ago
Pharma

Bris­tol My­er­s' $40B US in­vest­ment; Sh­iono­gi to buy Japan­ese drug­mak­er

2 months ago

Gilead re­veals plans to put an­oth­er $11B in­to US man­u­fac­tur­ing

2 months ago
R&D
Pharma

Te­va plans staff cuts as it com­mits to ac­cel­er­at­ing growth

2 months ago
Pharma

PhRMA says tar­iffs are 'not the an­swer' as in­dus­try trade probe clos­es for com­ments

2 months ago
Pharma
First page Previous page 12345 Next page Last page
A service from the Financial Times